This week on IPWatchdog Unleashed we enter the world of innovation politics with a discussion about what to expect for the patent world during President Trump's second term, what to specifically expect from the Patent Office, what to expect in Congress relating to the patent reform bills that we can expect to be reintroduced, which are namely PREVAIL, which relates to reforming the Patent Trial and Appeal Board (PTAB), the Patent Eligibility Restoration Act (PERA), which relates to reforming the law on patent eligibility to make it easier to patent software—including artificial intelligence—and to make medical diagnostics patentable again, and RESTORE, which relates to overruling the Supreme Court’s 2006 decision in eBay v. MercExchange, which has made it virtually impossible to obtain injunctive relief even when patent owners win and prove ongoing infringement.

The conversation that you will hear happened at the annual IPWatchdog PTAB Masters™ program, which was held at the end of January at IPWatchdog Studios. The panelists were Chief Judge Paul Michel, former Chief Judge of the United States Court of Appeals for the Federal Circuit, David Kappos, a partner with Cravath and a former Director of the Patent Office during President Obama's first term, and Chris Israel, who is a senior partner at American Continental Group and served in the George W. Bush White House as the first U.S. International Intellectual Property Enforcement Coordinator. Also joining the conversation is Scott McKeown, who is a shareholder at Wolf Greenfield and was Chair of the PTAB program. Scott, as most of you know, is also one of the leading experts on PTAB practice in the United States.

We discuss the almost certain reintroduction of PREVAIL, PERA, and RESTORE, as well as the odds of getting patent reform during this Congress—which no one thinks was very likely unless President Trump himself steps up and makes it a priority. We also discuss the “helter-skelter” nature of the U.S. patent system, where the pieces don't fit together, don't integrate, leads to low predictability, and innovation-killing reality that simply does not incentivize investment in innovation. We also discuss the Administrative Patent Judges (APJs) of the PTAB being ordered back to the Office, and what that will mean for the number of petitions challenging patents that could possibly be instituted. And we discuss how antitrust enforcement would be unnecessary if we had a strong patent system that let young companies compete fairly based on innovation merit, and how Elon Musk is almost dead-on correct when he says that patents are for the weak—although Chris Israel suggested it would make more sense to say that “patents are for the young”.

Visit us online at IPWatchdog.com.

You can also visit our channels at YouTube, LinkedIn, X, Instagram and Facebook.

Patents and the Future of the PTO in Trump's Second Term